CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer-Reference-Cited by-同舟云学术

CHEK2*1100delC homozygosity in the Netherlands—prevalence and risk of breast and lung cancer

Published:2013-05-08 Issue:1 Volume:22 Page:46-51
ISSN:1018-4813
Container-title:European Journal of Human Genetics
language:en
Short-container-title:Eur J Hum Genet

Author:

Huijts Petra EA,Hollestelle Antoinette,Balliu Brunilda,Houwing-Duistermaat Jeanine J,Meijers Caro M,Blom Jannet C,Ozturk Bahar,Krol-Warmerdam Elly MM,Wijnen Juul,Berns Els MJJ,Martens John WM,Seynaeve Caroline,Kiemeney Lambertus A,van der Heijden Henricus F,Tollenaar Rob AEM,Devilee Peter,van Asperen Christi J

Publisher

Springer Science and Business Media LLC

Subject

Genetics (clinical),Genetics

Link

http://www.nature.com/articles/ejhg201385.pdf

Reference44 articles.

1. Antoni L, Sodha N, Collins I, Garrett MD : CHK2 kinase: cancer susceptibility and cancer therapy —two sides of the same coin? Nat Rev Cancer 2007; 7: 925–936.

2. Bahassi el M, Penner CG, Robbins SB et al: The breast cancer susceptibility allele CHEK2*1100delC promotes genomic instability in a knock-in mouse model. Mutat Res 2007; 616: 201–209.

3. Meijers-Heijboer H, van den Ouweland A, Klijn J et al: Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations. Nat Genet 2002; 31: 55–59.

4. Hollestelle A, Wasielewski M, Martens JW, Schutte M : Discovering moderate-risk breast cancer susceptibility genes. Curr Opin Genet Dev 2010; 20: 268–276.

5. Vahteristo P, Bartkova J, Eerola H et al: A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer. Am J Hum Genet 2002; 71: 432–438.

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline variant profiling of CHEK2 sequencing variants in breast cancer patients;Cancer Genetics;2024-11

2. Comparing Cancer Risk Management between Females with Truncating CHEK2 1100delC versus Missense CHEK2 I157T Variants;Genes;2024-07-05

3. The genomic landscape of breast and non-breast cancers from individuals with germline CHEK2 deficiency;JNCI Cancer Spectrum;2024-06-07

4. The heterogeneous cancer phenotype of individuals with biallelic germline pathogenic variants in CHEK2;Genetics in Medicine;2024-05

5. Management of individuals with germline pathogenic/likely pathogenic variants in CHEK2: A clinical practice resource of the American College of Medical Genetics and Genomics (ACMG);Genetics in Medicine;2023-10